Entourage Health Corp. (ETRGF)
OTCMKTS
· Delayed Price · Currency is USD
0.0040
+0.0005 (14.29%)
Inactive · Last trade price
on Apr 8, 2025
Entourage Health Income Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2014 - 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2014 - 2018 |
| Revenue | 41.46 | 40.71 | 40.89 | 42.27 | 29.43 | 20.82 | Upgrade
|
| Revenue Growth (YoY) | 5.08% | -0.44% | -3.26% | 43.62% | 41.37% | 161.72% | Upgrade
|
| Cost of Revenue | 37.23 | 37.01 | 60.78 | 53.99 | 53.64 | 5.95 | Upgrade
|
| Gross Profit | 4.23 | 3.71 | -19.89 | -11.71 | -24.21 | 14.87 | Upgrade
|
| Selling, General & Admin | 19.95 | 25.12 | 29.77 | 28.73 | 27.64 | 18.19 | Upgrade
|
| Operating Expenses | 19.94 | 25.09 | 31.62 | 32.33 | 32.43 | 23.24 | Upgrade
|
| Operating Income | -15.71 | -21.38 | -51.51 | -44.04 | -56.64 | -8.36 | Upgrade
|
| Interest Expense | -26.85 | -24.39 | -17.19 | -10.77 | -5.82 | -1.24 | Upgrade
|
| Interest & Investment Income | - | - | - | - | 0.07 | 0.22 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.5 | -0.08 | -0.39 | -0.13 | -0.09 | -0.01 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.05 | 0.07 | 0.06 | 5.84 | 3.98 | -0.13 | Upgrade
|
| EBT Excluding Unusual Items | -43.01 | -45.77 | -69.03 | -49.11 | -58.5 | -9.53 | Upgrade
|
| Merger & Restructuring Charges | 0.42 | -0.96 | -0.52 | -0.47 | - | - | Upgrade
|
| Impairment of Goodwill | - | - | - | -6.01 | -16.12 | - | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | - | -0.23 | -0.07 | -0.87 | Upgrade
|
| Gain (Loss) on Sale of Assets | -0.02 | 0.11 | -0.02 | -0.49 | -0.45 | - | Upgrade
|
| Asset Writedown | -1.04 | -1.04 | -62.64 | -25.15 | -18.68 | - | Upgrade
|
| Other Unusual Items | - | - | 9.07 | 2.53 | 4.22 | - | Upgrade
|
| Pretax Income | -42.16 | -46.17 | -123.15 | -78.94 | -89.61 | -10.39 | Upgrade
|
| Net Income | -42.16 | -46.17 | -123.15 | -78.94 | -89.61 | -10.39 | Upgrade
|
| Net Income to Common | -42.16 | -46.17 | -123.15 | -78.94 | -89.61 | -10.39 | Upgrade
|
| Shares Outstanding (Basic) | 309 | 308 | 305 | 249 | 208 | 116 | Upgrade
|
| Shares Outstanding (Diluted) | 309 | 308 | 305 | 249 | 208 | 116 | Upgrade
|
| Shares Change (YoY) | 0.39% | 0.91% | 22.51% | 19.69% | 79.21% | 9.03% | Upgrade
|
| EPS (Basic) | -0.14 | -0.15 | -0.40 | -0.32 | -0.43 | -0.09 | Upgrade
|
| EPS (Diluted) | -0.14 | -0.15 | -0.40 | -0.32 | -0.43 | -0.09 | Upgrade
|
| Free Cash Flow | -6.02 | -11.44 | -31.86 | -30.46 | -36.72 | -62.45 | Upgrade
|
| Free Cash Flow Per Share | -0.02 | -0.04 | -0.10 | -0.12 | -0.18 | -0.54 | Upgrade
|
| Gross Margin | 10.21% | 9.11% | -48.64% | -27.71% | -82.24% | 71.43% | Upgrade
|
| Operating Margin | -37.88% | -52.51% | -125.96% | -104.18% | -192.43% | -40.17% | Upgrade
|
| Profit Margin | -101.69% | -113.40% | -301.15% | -186.73% | -304.43% | -49.91% | Upgrade
|
| Free Cash Flow Margin | -14.51% | -28.10% | -77.92% | -72.05% | -124.76% | -299.96% | Upgrade
|
| EBITDA | -15.07 | -20.99 | -45.66 | -37.95 | -49.64 | -8.08 | Upgrade
|
| EBITDA Margin | -36.34% | -51.57% | -111.65% | -89.78% | -168.64% | -38.83% | Upgrade
|
| D&A For EBITDA | 0.64 | 0.38 | 5.85 | 6.09 | 7 | 0.28 | Upgrade
|
| EBIT | -15.71 | -21.38 | -51.51 | -44.04 | -56.64 | -8.36 | Upgrade
|
| EBIT Margin | -37.88% | -52.51% | -125.96% | -104.18% | -192.43% | -40.17% | Upgrade
|
| Revenue as Reported | 41.46 | 40.71 | 40.89 | 42.27 | 29.43 | 20.82 | Upgrade
|
Updated Nov 28, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.